Saltar al contenido
Merck

700042P

Avanti

4β-hydroxycholesterol-d7

Avanti Research - A Croda Brand

Sinónimos:

cholest-5-ene-3b,4b-diol(d7)

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización


About This Item

Fórmula empírica (notación de Hill):
C27H39O2D7
Número de CAS:
Peso molecular:
409.70
Número MDL:
Código UNSPSC:
12352100
NACRES:
NA.25
En este momento no podemos mostrarle ni los precios ni la disponibilidad

descripción

cholest-5-ene-3,4-diol-d7

Ensayo

>99% (TLC)

Formulario

powder

envase

pkg of 1 × 1 mg (700042P-1mg)

fabricante / nombre comercial

Avanti Research - A Croda Brand

Condiciones de envío

dry ice

temp. de almacenamiento

−20°C

cadena SMILES

O[C@@H]1[C@@H](C2=CC[C@H]3[C@H]4[C@@]([C@H](CC4)[C@@H](CCCC(C([2H])([2H])[2H])(C([2H])([2H])[2H])[2H])C)(CC[C@@H]3[C@]2(CC1)C)C)O

InChI

1S/C27H46O2/c1-17(2)7-6-8-18(3)20-11-12-21-19-9-10-23-25(29)24(28)14-16-27(23,5)22(19)13-15-26(20,21)4/h10,17-22,24-25,28-29H,6-9,11-16H2,1-5H3/t18-,19+,20-,21+,22+,24+,25-,26-,27-/m1/s1/i1D3,2D3,17D

Clave InChI

CZDKQKOAHAICSF-BZNWTYAPSA-N

Descripción general

4β-hydroxycholesterol (4β-HC) is a catabolic product of cholesterol metabolism mediated by the enzyme cytochrome P450 family 3 subfamily A member 4 (CYP3A4).[1] 4β-hydroxycholesterol-d7 is the deuterated form of 4β-hydroxycholesterol.

Aplicación

4β-hydroxycholesterol-d7 has been used:
  • as an internal standard to spike plasma samples ultra-high-pressure liquid,chromatography–tandem mass spectrometry (UHPLC-MS/MS) analysis[1]
  • to spike serum samples for mass spectrometry measurements[2]
  • as an internal standard for the quantification of human colon biopsies samples using HPLC-MS[3]

Acciones bioquímicas o fisiológicas

4β-hydroxycholesterol (4β-HC) may function as a liver X receptor ligand.[3] The levels of 4β-HC are elevated in dextran sulfate induced colitis along with other oxysterols and it may promote colon inflammation.[3]

Envase

5 mL Amber Glass Screw Cap Vial (700042P-1mg)

Información legal

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Código de clase de almacenamiento

11 - Combustible Solids


Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documentos section.

Si necesita más asistencia, póngase en contacto con Atención al cliente

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Owein Guillemot-Legris et al.
Journal of Crohn's & colitis, 13(2), 218-229 (2018-10-09)
Inflammatory bowel diseases [IBD] represent a challenging health issue with a complex aetiology involving genetic and environmental parameters. Although our understanding of the pathophysiology of IBD has improved, much remains to be explored. In this context, bioactive lipids, more specifically
Sarah J Woolsey et al.
Basic & clinical pharmacology & toxicology, 118(4), 284-291 (2015-09-25)
Due to high basal interindividual variation in cytochrome P450 3A (CYP3A) activity and susceptibility to drug interactions, there has been interest in the application of efficient probe drug phenotyping strategies, as well as endogenous biomarkers for assessment of in vivo
Mahmoud Hasan et al.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1033-1034, 193-199 (2016-08-28)
Cytochrome P450 3A (CYP) enzymes are involved in the elimination of many drugs and are known to be regulated by several environmental factors. Thus, it was the aim of this study to develop and validate an analytical method allowing estimation

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico